Detalles de la búsqueda
1.
An artificial neural network model based on DNA damage response genes to predict outcomes of lower-grade glioma patients.
Brief Bioinform
; 22(6)2021 11 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34015817
2.
Pharmacokinetics, pharmacodynamics and efficacy of pemigatinib (a selective inhibitor of fibroblast growth factor receptor 1-3) monotherapy in Chinese patients with advanced solid tumors: a phase i clinical trial.
Invest New Drugs
; 41(6): 808-815, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37889382
3.
Paracrine secretion of IL8 by breast cancer stem cells promotes therapeutic resistance and metastasis of the bulk tumor cells.
Cell Commun Signal
; 21(1): 59, 2023 03 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36915147
4.
LncRNA H19 Regulates Breast Cancer DNA Damage Response and Sensitivity to PARP Inhibitors via Binding to ILF2.
Int J Mol Sci
; 24(11)2023 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37298108
5.
Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy.
BMC Cancer
; 21(1): 700, 2021 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34126950
6.
Predicting pathologic response to neoadjuvant chemotherapy in patients with locally advanced breast cancer using multiparametric MRI.
BMC Med Imaging
; 21(1): 155, 2021 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34688263
7.
A novel fluorescent sensor for specific recognition of GSH based on the copper complex and its bioimaging in living cells.
Bioorg Chem
; 100: 103923, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32417525
8.
Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis.
J Cell Biochem
; 120(10): 16900-16912, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31081967
9.
A BODIPY-Based Water-Soluble Fluorescent Probe for Naked Eye Detection of pH.
J Fluoresc
; 29(6): 1423-1429, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31758369
10.
Preassembly Strategy To Fabricate Porous Hollow Carbonitride Spheres Inlaid with Single Cu-N3 Sites for Selective Oxidation of Benzene to Phenol.
J Am Chem Soc
; 140(49): 16936-16940, 2018 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30499302
11.
Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer.
Cancer Cell Int
; 18: 168, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30386177
12.
Addition to "Preassembly Strategy To Fabricate Porous Hollow Carbonitride Spheres Inlaid with Single Cu-N3 Sites for Selective Oxidation of Benzene to Phenol".
J Am Chem Soc
; 144(2): 1066, 2022 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34985876
13.
MiR-20a-5p promotes radio-resistance by targeting Rab27B in nasopharyngeal cancer cells.
Cancer Cell Int
; 17: 32, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28265202
14.
Nimotuzumab Combined with Chemotherapy is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer.
Med Sci Monit
; 23: 412-418, 2017 Jan 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28115730
15.
Analyses of hypoxia-related risk factors and clinical relevance in breast cancer.
Front Oncol
; 14: 1350426, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38500661
16.
Development of a multiparametric model for predicting the response to neoadjuvant chemotherapy in breast cancer.
Transl Cancer Res
; 13(2): 558-568, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38482410
17.
LINC00460-FUS-MYC feedback loop drives breast cancer metastasis and doxorubicin resistance.
Oncogene
; 43(17): 1249-1262, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418543
18.
Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion.
Cancer Res
; 84(8): 1270-1285, 2024 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38335272
19.
Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.
Front Immunol
; 14: 1073550, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814908
20.
Association between platelet-to-lymphocyte ratio and outcomes in HER2-positive advanced breast cancer patients treated with pyrotinib: a retrospective study.
Transl Cancer Res
; 12(10): 2726-2741, 2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37969380